Market Size –
The chemoinformatics market size has grown steadily in recent years. It will grow from $4.28 billion in 2023 to $4.4 billion in 2024 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to high throughput screening (hts), data availability, drug discovery efficiency, personalized medicine, artificial intelligence (ai) and machine learning.
The chemoinformatics market size is expected to see steady growth in the next few years. It will grow to $4.94 billion in 2028 at a compound annual growth rate (CAGR) of 3.0%. The growth in the forecast period can be attributed to biological data integration, structural biology, data management and security, regulatory compliance, drug discovery efficiency. Major trends in the forecast period include high-throughput screening, structural biology integration, biological data mining, virtual chemical libraries, personalized medicine.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/chemoinformatics-global-market-report
Scope Of Chemoinformatics Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Chemoinformatics Market Overview
Market Drivers –
The surging prevalence of chronic diseases is expected to propel the growth of the chemoinformatic market going forward. Chronic diseases refer to illnesses that last a year or longer and require ongoing medical attention. The rising number of chronic diseases such as neglected tropical diseases demands the need for new drug discoveries and the search for novel chemicals for their treatment, for which chemoinformatic is used. For instance, according to the World Health Organization, a Switzerland-based organization for international public health, between 2020 and 2030, 500 million people are expected to develop chronic diseases such as obesity, diabetes, heart diseases, or other noncommunicable diseases (NCDs) due to physical inactivity, if governments globally do no take immediate action to promote exercises. Therefore, the surging prevalence of chronic diseases is driving the demand for the chemoinformatic market.
The chemoinformatics market covered in this report is segmented –
1) By Type: Chemistry, Computer Science, Information Science
2) By Application: Chemical Analysis, Drug Discovery and Validation, Virtual Screening, Other Applications
3) By End User: Chemical and Pharmaceutical Industries, Research and Academic Institution, Other End Users
Get an inside scoop of the chemoinformatics market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=7806&type=smp
Regional Insights –
North America was the largest region in the chemoinformatics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemoinformatics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the chemoinformatics market include ChemAxon Ltd., Jubilant Biosys Inc., BIOVIA, OpenEye Scientific Software Inc., Schrödinger Inc., Advanced Chemistry Development Inc, Scilligence Corporation, Dassault Systemes SE, Chemical Computing Group Inc, Collaborative Drug Discovery Inc., UVJ Technologies, Golden Helix Inc., KNIME.COM Aktiengesellschaft, Simulations Plus Inc., Agilent Technologies Inc., Cambridgesoft Corp., Bio-Rad Laboratories Inc., Molecular Discovery Ltd., Optibrium Ltd., Cresset Group Ltd., Dotmatics Ltd., Genedata AG, Inte:Ligand GmbH, MolPort Inc., PerkinElmer Inc., Cheminformatics LLC, Chemspace, InfoChem GmbH, Molecular Networks GmbH, VLife Sciences Technologies Pvt. Ltd., Xemistry GmbH, Cheminnovation Software Inc.
Table of Contents
1. Executive Summary
2. Chemoinformatics Market Report Structure
3. Chemoinformatics Market Trends And Strategies
4. Chemoinformatics Market – Macro Economic Scenario
5. Chemoinformatics Market Size And Growth
…..
27. Chemoinformatics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
